FDA Extends Approval of PKU Drug to Include Adolescents

Previously only approved for adults, BioMarin’s pegvaliase-pqpz (PALYNZIQ) is now licensed for patients as young as 12 years.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-extends-approval-pku-drug-include-adolescents-2026a10006y2?src=rss

Author :

Publish date : 2026-03-06 11:44:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

FDA Extends Approval of PKU Drug to Include Adolescents

Children With OSA Have Greater Risk for Flu and COVID

Risk Factors for Childbirth-Related PTSS Vary in Parents

Related Posts

Parent Stress Emerges as Key Factor in Child Obesity

Menopause Linked to Higher Risk of Depression, Bipolar Disorder

How an intern helped build the AI that shook the world

The moment that kicked off the AI revolution

FDA’s Controversial Vaccine Chief Exits … Again

Hospitals, Drugmakers, and U.S. Government Continue Battle Over 340B Program

Parent Stress Emerges as Key Factor in Child Obesity

Menopause Linked to Higher Risk of Depression, Bipolar Disorder

How an intern helped build the AI that shook the world

The moment that kicked off the AI revolution

FDA’s Controversial Vaccine Chief Exits … Again

Hospitals, Drugmakers, and U.S. Government Continue Battle Over 340B Program

Model Could Sound the Alarm on Preeclampsia Risk in Late Pregnancy

Pre-Op Chemo or Upfront Surgery in Colon Cancer: Is One Strategy Best?

Categories

Archives